Your session is about to expire
← Back to Search
Fat Cell Injection for Knee Osteoarthritis (SVF Trial)
SVF Trial Summary
This trial is testing a single injection of a person's own fat cells to treat knee osteoarthritis after an injury.
SVF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SVF Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have painful arthritis in my hips, spine, or ankle that affects my knee's condition.I have a condition like gout, lupus, or severe knee issues.I am in good health with a BMI under 35.I am on long-term oral steroids or drugs for rheumatic diseases.I can attend all required follow-up and procedure visits.I have not had any knee injections in the last 3 months.I am not pregnant nor planning to become pregnant during the study.I have had chemotherapy or radiation on the leg or site where fat was taken for treatment.I still have knee pain after trying at least two treatments for over 3 months.I am allergic to lidocaine, epinephrine, valium, or similar sedatives.I have been diagnosed with moderate to severe arthritis due to an injury.My knee pain is due to severe cartilage damage or swelling.I have been diagnosed with chondrocalcinosis, Paget's disease, or Villonodular synovitis.I have not had knee surgery in the last 12 months.I haven't used any immunosuppressants in the last 6 weeks.I am between 18 and 45 years old and had a major knee injury or surgery due to trauma between 1 and 20 years ago.I cannot stop my blood thinner medication for an injection.I have knee pain rated above 4, and if both knees are affected, the other is not worse than 3.I am willing to stop taking pain and anti-inflammatory meds for 7 days before visits.I am willing to sign the consent and HIPAA forms for the study.I am between 18 and 45 years old and had a major knee injury or surgery due to trauma between 1 and 20 years ago.
- Group 1: a single injection of autologous Adipose Derived (AD) Stromal Vascular Fraction (SVF)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are minors allowed to participate in this experiment?
"Patients aged 18 to 45 are eligible for this clinical trial, whereas there are 30 other trials open for minors and 583 for seniors."
Are there still vacancies for individuals in this clinical trial?
"According to the clinicaltrials.gov, this particular trial has not been actively recruiting patients since October 31st 2022 and is currently inactive. Despite this, 613 other studies are presently enrolling individuals for their respective research initiatives."
Who would be eligible to join this research endeavor?
"In order to be considered for the trials, potential participants must possess arthrosis and fall between 18-45 years old. A total of 10 patients will eventually join this research project."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger